BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

341 related articles for article (PubMed ID: 31666276)

  • 21. Adult onset haemophagocytic lymphohistiocytosis prognosis is affected by underlying disease: analysis of a single-institution series of 174 patients.
    Zhang Q; Li L; Zhu L; Zhu J; Yang X; Zhou D; Zheng Y; Zhu M; Xie M; Sun J; Li X; Wu Y; Wei Z; Xie W; Ye X
    Swiss Med Wkly; 2018 Sep; 148():w14641. PubMed ID: 30378643
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Biomarkers for Early Diagnosis of Hemophagocytic Lymphohistiocytosis in Critically Ill Patients.
    Debaugnies F; Mahadeb B; Nagant C; Meuleman N; De Bels D; Wolff F; Gottignies P; Salaroli A; Borde P; Voué M; Corazza F
    J Clin Immunol; 2021 Apr; 41(3):658-665. PubMed ID: 33417087
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical and laboratory signs of haemophagocytic lymphohistiocytosis associated with pandemic influenza A (H1N1) infection in patients needing extracorporeal membrane oxygenation: A retrospective observational study.
    von Bahr Greenwood T; Holzgraefe B; Chiang SCC; Wang Y; Tesi B; Bryceson YT; Henter JI
    Eur J Anaesthesiol; 2021 Jul; 38(7):692-701. PubMed ID: 33186307
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Can we truly diagnose adult secondary hemophagocytic lymphohistiocytosis (HLH)? A critical review of current paradigms.
    Naymagon L
    Pathol Res Pract; 2021 Feb; 218():153321. PubMed ID: 33418346
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Haemophagocytic syndrome and COVID-19.
    Retamozo S; Brito-Zerón P; Sisó-Almirall A; Flores-Chávez A; Soto-Cárdenas MJ; Ramos-Casals M
    Clin Rheumatol; 2021 Apr; 40(4):1233-1244. PubMed ID: 33389315
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hemophagocytic Lymphohistiocytosis During HIV Infection in Cayenne Hospital 2012-2015: First Think Histoplasmosis.
    Nguyen D; Nacher M; Epelboin L; Melzani A; Demar M; Blanchet D; Blaizot R; Drak Alsibai K; Abboud P; Djossou F; Couppié P; Adenis A
    Front Cell Infect Microbiol; 2020; 10():574584. PubMed ID: 33072627
    [No Abstract]   [Full Text] [Related]  

  • 27. Diagnostic evaluation of patients with suspected haemophagocytic lymphohistiocytosis.
    Lehmberg K; Ehl S
    Br J Haematol; 2013 Feb; 160(3):275-87. PubMed ID: 23206255
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Haemophagocytic lymphohistiocytosis: A fulminant syndrome associated with multiorgan failure and high mortality that frequently masquerades as sepsis and shock.
    Price B; Lines J; Lewis D; Holland N
    S Afr Med J; 2014 May; 104(6):401-6. PubMed ID: 25214245
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Investigation of hemophagocytic lymphohistiocytosis in severe sepsis patients.
    Halacli B; Unver N; Halacli SO; Canpinar H; Ersoy EO; Ocal S; Guc D; Buyukasik Y; Topeli A
    J Crit Care; 2016 Oct; 35():185-90. PubMed ID: 27481757
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High soluble interleukin-2 receptor values in Indian paediatric & adult controls - Need for population-specific threshold in the diagnosis of haemophagocytic lymphohistiocytosis.
    Dinand V; Sachdeva A; Sharma S; Prasad A; Pant D; Sachdev A; Ganguly NK
    Indian J Med Res; 2021 Jun; 154(6):843-848. PubMed ID: 35662089
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hemophagocytic lymphohistiocytosis: a potentially underrecognized association with systemic inflammatory response syndrome, severe sepsis, and septic shock in adults.
    Raschke RA; Garcia-Orr R
    Chest; 2011 Oct; 140(4):933-938. PubMed ID: 21737492
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The 2022 EULAR/ACR points to consider at the early stages of diagnosis and management of suspected haemophagocytic lymphohistiocytosis/macrophage activation syndrome (HLH/MAS).
    Shakoory B; Geerlinks A; Wilejto M; Kernan K; Hines M; Romano M; Piskin D; Ravelli A; Sinha R; Aletaha D; Allen C; Bassiri H; Behrens EM; Carcillo J; Carl L; Chatham W; Cohen JI; Cron RQ; Drewniak E; Grom AA; Henderson LA; Horne A; Jordan MB; Nichols KE; Schulert G; Vastert S; Demirkaya E; Goldbach-Mansky R; de Benedetti F; Marsh RA; Canna SW;
    Ann Rheum Dis; 2023 Oct; 82(10):1271-1285. PubMed ID: 37487610
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Haemophagocytic lymphohistiocytosis in patients treated with immune checkpoint inhibitors: analysis of WHO global database of individual case safety reports.
    Noseda R; Bertoli R; Müller L; Ceschi A
    J Immunother Cancer; 2019 May; 7(1):117. PubMed ID: 31046841
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interleukin 1 Receptor Antagonist Anakinra, Intravenous Immunoglobulin, and Corticosteroids in the Management of Critically Ill Adult Patients With Hemophagocytic Lymphohistiocytosis.
    Wohlfarth P; Agis H; Gualdoni GA; Weber J; Staudinger T; Schellongowski P; Robak O
    J Intensive Care Med; 2019 Sep; 34(9):723-731. PubMed ID: 28631531
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hemophagocytic lymphohistiocytosis in adults: collaborative analysis of 137 cases of a nationwide German registry.
    Birndt S; Schenk T; Heinevetter B; Brunkhorst FM; Maschmeyer G; Rothmann F; Weber T; Müller M; Panse J; Penack O; Schroers R; Braess J; Frickhofen N; Ehl S; Janka G; Lehmberg K; Pletz MW; Hochhaus A; Ernst T; La Rosée P
    J Cancer Res Clin Oncol; 2020 Apr; 146(4):1065-1077. PubMed ID: 32076823
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The 2022 EULAR/ACR Points to Consider at the Early Stages of Diagnosis and Management of Suspected Haemophagocytic Lymphohistiocytosis/Macrophage Activation Syndrome (HLH/MAS).
    Shakoory B; Geerlinks A; Wilejto M; Kernan K; Hines M; Romano M; Piskin D; Ravelli A; Sinha R; Aletaha D; Allen C; Bassiri H; Behrens EM; Carcillo J; Carl L; Chatham W; Cohen JI; Cron RQ; Drewniak E; Grom AA; Henderson LA; Horne A; Jordan MB; Nichols KE; Schulert G; Vastert S; Demirkaya E; Goldbach-Mansky R; de Benedetti F; Marsh RA; Canna SW
    Arthritis Rheumatol; 2023 Oct; 75(10):1714-1732. PubMed ID: 37486733
    [TBL] [Abstract][Full Text] [Related]  

  • 37. HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS IN PREGNANT AND POSTPARTUM WOMEN.
    Obuchowska A; Kamiński M; Kimber-Trojnar Ż; Grzesik P; Standyło A; Turżańska K; Leszczyńka-Gorzelak B
    Wiad Lek; 2020; 73(9 cz. 1):1844-1847. PubMed ID: 33099527
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A comprehensive analysis of adult patients with secondary hemophagocytic lymphohistiocytosis: a prospective cohort study.
    Yoon SE; Eun Y; Huh K; Chung CR; Yoo IY; Cho J; Cho D; Ko YH; Park S; Kim WS; Kim SJ
    Ann Hematol; 2020 Sep; 99(9):2095-2104. PubMed ID: 32440790
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A clinicopathological analysis of 26 patients with infection-associated haemophagocytic lymphohistiocytosis and the importance of bone marrow phagocytosis for the early initiation of immunomodulatory treatment.
    Nair V; Das S; Sharma A; Sharma S; Sharma P; Ray S; Bhattacharya S
    Postgrad Med J; 2013 Apr; 89(1050):185-92. PubMed ID: 23243150
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Treatment of hemophagocytic lymphohistiocytosis in patients in the intensive care unit].
    Eichenauer DA; La Rosée P
    Inn Med (Heidelb); 2023 Oct; 64(10):955-960. PubMed ID: 37702780
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.